Response to: Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
J Glaucoma
.
2020 Oct;29(10):e120.
doi: 10.1097/IJG.0000000000001619.
Authors
Jeanette Du
1
,
James T Patrie
2
,
Bruce E Prum
3
,
Peter A Netland
3
,
Yevgeniy Eugene Shildkrot
3
Affiliations
1
University of Virginia School of Medicine.
2
University of Virginia Department of Public Health Sciences.
3
University of Virginia Department of Ophthalmology, Charlottesville, VA.
PMID:
32740507
DOI:
10.1097/IJG.0000000000001619
No abstract available
Publication types
Letter
Comment
MeSH terms
Bevacizumab
Glaucoma*
Humans
Intraocular Pressure*
Substances
Bevacizumab